Superior mesenteric vein thrombosis (SMVT) is a blood clot in the large vein that drains the small intestine and part of the colon into the portal vein. It is uncommon, but it matters because a blocked vein can back up blood in the bowel wall and, if untreated, cause intestinal ischemia and infarction. Most patients are diagnosed with a contrast CT scan and treated with anticoagulation, and outcomes are good when the clot is caught before the bowel is damaged.
Below I walk through what the superior mesenteric vein does, why clots form there, how the condition presents, how we confirm it, and what treatment and recovery usually look like.
What Is Superior Mesenteric Vein Thrombosis?
The superior mesenteric vein (SMV) collects blood from the small intestine, the cecum, the ascending colon and most of the transverse colon. Behind the neck of the pancreas it joins the splenic vein to form the portal vein, which carries nutrient-rich blood to the liver.
When a clot forms in the SMV, blood can still flow into the intestine through the arteries but cannot drain out properly. The bowel wall becomes congested and swollen, fluid leaks into the tissues, and in severe cases the oxygen supply fails. This is called venous mesenteric ischemia, and it is one of the less common forms of mesenteric ischemia compared with arterial blockage.
SMVT can be acute, with sudden symptoms over days, or chronic, where a long-standing clot is found by chance on imaging. Chronic cases often develop collateral veins that reroute blood, so the bowel is usually spared.
Causes and Risk Factors
Clots in the mesenteric veins follow the same rules as clots anywhere else. Clinicians describe these using Virchow’s triad: injury to the vessel wall, slowed or turbulent blood flow, and hypercoagulability, meaning blood that clots more readily than it should. Most patients with SMVT have at least one identifiable risk factor, and many have more than one.
| Category | Examples | Main mechanism |
|---|---|---|
| Inherited thrombophilia | Factor V Leiden, prothrombin gene mutation, protein C, protein S or antithrombin deficiency | Hypercoagulability |
| Acquired clotting tendency | Antiphospholipid syndrome, estrogen-containing contraceptives, pregnancy | Hypercoagulability |
| Myeloproliferative neoplasms | Polycythemia vera, essential thrombocythemia (often JAK2-positive) | Hypercoagulability |
| Abdominal inflammation | Pancreatitis, inflammatory bowel disease, diverticulitis, appendicitis | Local vessel injury and inflammation |
| Liver disease | Cirrhosis with portal hypertension | Slow portal flow |
| Cancer | Pancreatic, liver and other abdominal tumors | Compression, invasion and hypercoagulability |
| Surgery or trauma | Splenectomy, bariatric surgery, abdominal injury | Endothelial injury and altered flow |
In my practice, one group deserves special mention: patients with an unusual-site clot like SMVT and no obvious trigger. These patients should be checked for a myeloproliferative neoplasm and for paroxysmal nocturnal hemoglobinuria, because both can present first as abdominal vein thrombosis, sometimes before the blood counts look abnormal.
Signs and Symptoms
The hallmark of acute SMVT is abdominal pain that seems out of proportion to the physical examination. The pain is often around the navel, may build over several days, and the abdomen can feel surprisingly soft early on.
- Crampy or constant mid-abdominal pain
- Nausea, vomiting and loss of appetite
- Diarrhea or, less often, constipation
- Abdominal bloating and distension
- Blood in the stool or dark, tarry stool in more advanced cases
- Fever, rapid heart rate and low blood pressure if the bowel is becoming ischemic
Warning signs of bowel infarction include guarding, rebound tenderness, a rigid abdomen and signs of shock. These point to peritonitis and need urgent surgical assessment. Chronic SMVT may cause no symptoms at all, or it may show up as complications of portal hypertension such as an enlarged spleen or varices.
How SMVT Is Diagnosed
Because the symptoms are nonspecific, diagnosis depends on a clinician thinking of it. The key test is contrast-enhanced CT of the abdomen and pelvis in the venous (portal venous) phase. It shows the clot as a filling defect in the SMV and also reveals bowel wall thickening, mesenteric swelling, free fluid, or gas in the bowel wall that would suggest infarction.
Other imaging has supporting roles. Doppler ultrasound can show absent flow in the portal and mesenteric veins but is limited by bowel gas. MR venography is an alternative when iodinated contrast must be avoided. Conventional angiography is now used mainly when an interventional procedure is planned.
Blood tests are not diagnostic, but they help assess severity and look for a cause. A raised white cell count, elevated lactate or metabolic acidosis may point to bowel compromise, though a normal lactate does not rule it out. Liver tests, pancreatic enzymes, a full blood count and inflammatory markers such as C-reactive protein round out the picture. Once the patient is stable, the clinician works through the causes listed above.
Treatment and Management
Anticoagulation is the cornerstone of treatment and should begin as soon as the diagnosis is made, unless there is active bleeding. It stops the clot from extending, allows the body’s own fibrinolytic system to break it down, and reduces the risk of bowel infarction.
- Initial therapy: usually unfractionated heparin or low-molecular-weight heparin. Unfractionated heparin is often preferred when surgery may be needed because it can be stopped quickly.
- Longer-term therapy: transition to warfarin or a direct oral anticoagulant (DOAC) once the patient is eating and stable. DOAC choice is individualized, particularly in people with cirrhosis.
- Duration: typically at least 3 to 6 months for a clot with a reversible trigger, and often indefinite when the risk factor persists, such as a myeloproliferative neoplasm or a strong thrombophilia.
Interventional and Surgical Options
If symptoms worsen despite anticoagulation, interventional radiology may offer catheter-directed thrombolysis or mechanical thrombectomy, delivered through the liver (transhepatic) or via the superior mesenteric artery. These procedures carry bleeding risk and are reserved for selected patients in experienced centers.
Surgery is needed when there are signs of peritonitis or bowel infarction. The surgeon removes dead bowel and often plans a second-look operation a day or two later to check the remaining intestine. Anticoagulation continues around the surgery, which is why these cases are best managed jointly by surgeons, gastroenterologists, radiologists and hematologists.
Outlook and Recovery
When diagnosed before infarction and treated promptly with anticoagulation, most patients recover well and many clots partially or fully recanalize over months. Outcomes are worse when the bowel has already died, when large lengths of intestine must be removed, or when a serious underlying cause such as advanced cancer is present. Follow-up imaging is often arranged to confirm the clot has not progressed.
When to See a Doctor
Seek emergency care for severe or worsening abdominal pain, especially if you have a known clotting disorder, liver disease, recent abdominal surgery or pancreatitis, or you take estrogen. Blood in the stool, vomiting that will not settle, fever or feeling faint alongside abdominal pain should never be watched at home.
If you are already on anticoagulation for SMVT, contact your care team about new bleeding, black stools, or a return of abdominal pain. Do not stop your blood thinner without discussing it first.
Frequently Asked Questions
Is superior mesenteric vein thrombosis life-threatening?
It can be, mainly when it leads to bowel infarction, which is a surgical emergency. When the clot is found early and anticoagulation is started, most patients avoid that complication. The underlying cause also shapes the long-term outlook.
How long will I need blood thinners?
Most people take anticoagulants for at least 3 to 6 months. If the clot was triggered by a temporary cause such as surgery or pancreatitis, treatment may then stop. If the risk factor is ongoing, your hematologist may recommend lifelong treatment.
Why was I tested for a blood disorder after an abdominal clot?
Clots in unusual places like the mesenteric veins are more often linked to conditions such as myeloproliferative neoplasms, paroxysmal nocturnal hemoglobinuria and inherited thrombophilias. Finding one of these changes how long treatment lasts and may call for specific therapy.
Can SMVT come back?
Recurrence is possible, especially after anticoagulation stops in someone with a persistent risk factor. That is why the decision about treatment length weighs the recurrence risk against the bleeding risk of staying on a blood thinner.
Key Takeaways
- SMVT is a clot in the vein that drains the small intestine, and it can cause venous mesenteric ischemia.
- Risk factors include thrombophilia, myeloproliferative neoplasms, cirrhosis, abdominal inflammation, cancer and recent surgery.
- Pain out of proportion to examination findings is the classic clue; contrast CT in the venous phase confirms the diagnosis.
- Prompt anticoagulation is the main treatment, with intervention or surgery for deterioration or bowel infarction.
- For more on how clots form and are treated, see our blood clotting guide.
